Concepedia

Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial

Chijioke Bennett, Wayne Woo, Mark Bloch, King Cheung, Paul Griffin, Rahul Mohan, Sachin Kumar Deshmukh, Mark Arya, Oscar Cumming, A. Munro Neville,

The Lancet Infectious Diseases · 2024 · 19 citations · 17 references

Open access

References

17

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.5K citations · Full text

Veterinary Medicine, Biomedical Sciences, Infectious Diseases +17

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New England Journal of Medicine · 2020 · 10.7K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Comparative analysis of two rates

Olli S. Miettinen, Markku Nurminen · Statistics in Medicine · 1985 · 1.1K citations

Education, Biostatistics, Mathematics +16

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine

New England Journal of Medicine · 2021 · 1.1K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Bivalent Omicron-Containing Booster Vaccine against Covid-19

Spyros Chalkias, Charles Harper, Keith Vrbicky et al. · New England Journal of Medicine · 2022 · 649 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17